Invasive aspergillus sinusitis in patients with human immunodeficiency virus infection report of 2 cases and review

Medicine

Volumn 76, Issue 4, 1997, Pages 249-255

  Mylonakis, Eleftherios ^a,b,c   Rich, Josiah ^a   Skolnik, Paul R ^a   De Orchis, Douglas F ^a   Flanigan, Timothy ^a  

^a BROWN UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MIRIAM HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; CASE REPORT; FEMALE; FEVER; FUNGUS IDENTIFICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MALE; NOSE SECRETION; PRIORITY JOURNAL; SINUSITIS;

ABSCESS; ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; FEMALE; HUMANS; MALE; PSEUDOMONAS AERUGINOSA; SINUSITIS;

EID: 0030849734     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-199707000-00003     Document Type: Article

References (49)

1. Anaissie E. Opportunistic mycoses in the inununocompromised host: Experience at a cancer center and review. Clin Infect Dis 14 (Suppl 1): S43-53, 1992.
2. Barchiesi F, Colombo AL, McGough DA, Rinaldi MG. Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Commitee for Clinical Laboratory Standards' proposed standard. J Clin Slicrobio!32:2494-2500, 1994.
3. Blatt SP, Lucey DR, Delloff D, Zellmer PB. Rhinocerebral zygomycosis in a paüent with AIDS [letter]. J Infect Dis 164:215-16, 1991.
4. Carrazana EJ, Rossitch E Jr, Morris J. Isolated central nervous system aspergillosis in the acquired immunodeficiency syndrome (AIDS). Clin Neurol Neurosurg 93:227-30, 1991.
5. Choi SS, Lawson W, Bottone EJ, Biller HF. Cryptococcal sinusitis: A case report and review of the literature. Otolaryngol Head Neck Surg 99:414-18, 1988.
6. Colmenero C, Monux A, Valencia E, Castro A. Successfully treated Candida sinusitis in an AIDS patient J Craniomaxillofac Surg 18: 175-78, 1990.
7. De Carpentier JP, Ramamurthy L, Denning DW, Taylor PH. An algorithmic approach to Aspergillus sinusitis. J Laryngol Otol 108:314-18, 1994.
8. Denning DW, Follansbee SE, Scolaro M, Norris S, Edelstein H, Stevens DA. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med 324: 654-S2, 1991.
9. Denning DW, Lee JY, Hosteller JS, Pappas P, Kauffman CA, Dewsnup DH, Galgiani JN, GraybUlJR, Sugar AM, Catanzaro A, GaUis H, Perfect JR, Dockery B, Dismukes WE, Stevens DA. NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergUlosis. Am J Med 97:135-44, 1994.
10. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: Review of 2, 121 published cases. Rev Infect Dis 12: 1027-34, 1990.
11. Dupont B. Itraconazole therapy in aspergillosis: Study in 49 patients. J Am Acad Dermatol 23:607-14, 1990.
12. Frazier R, Gathe J Jr, Stool E, LeBlanc M, Nichols SI, Flaitz C. Head and neck zygomycete/Aspergillus infections in patients with AIDS [abstract No PO-B09-1365J. In: Program and abstracts of the IXth international conference on AIDS (Berlin), 1993.
13. Geissmann F, Viard JF, Henniquin C, Zylberberg L, Descamps-Latscha B. AspergiUus brain abscesses: Therapeutic effect of G-CSF and liposomal amphotericin B. In: Program and abstracts of the Xth international conference on AIDS (Yokohama), 1994.
14. Godofsky EW, Zinreich J, Armstrong SI, Leslie JM, Weikel CS. Sinusitis in HIV-infected patients: A clinical and radiographie review. Am J Med 93:163-70, 1992.
15. Hall PJ, Farrior JB. Aspergillus mastoiditis. Otolaryngol Head Neck Surg 108:167-70, 1993.
16. Hiemenz JW, Walsh TJ. Lipid formulations of amphotericin B: Recent progress and future directions. Clin Infect Dis 22(SuppI 2): S133-43, 1996.
17. Holliday RA. Manifestations of AIDS in the oromaxillofacial region. The role of imaging. Radiol Clin North Am 31:45-CO, 1993.
18. Hospenthal DR, Byrd JC, Weiss RB. Successful treatment of invasive aspergillosis complicating prolonged treatment-related neutropenia in acute myelogenous leukemia with amphotericin B lipid complex. Med Pediatr Oncol 25:119-22, 1995.
19. Jahrsdocrfer RA, Ejercito VS, Johns MME, CantreU RW, Sydnor JB. Aspergillosis of the nose and paranasal sinuses. Am J Otolaryngol 1:6-14, 1979.
20. Just-Nubling G, Ganger G, Hettenkofer M, Hoika R, Helm EB, Keui HG, Hubner K, Stille W. Therapeutic outcome in AIDS patients with aspergillosis lung-infection [abstract no. PO-B09-1409]. In: Programs and abstracts of the DCth international conference on AIDS (Berlin), 1993.
21. Kauffman CA. Role of azoles in antifungal therapy. Clin Infect Dis 22(Suppl2): S14S-S3, 1996.
22. Khoo SH, Denning DW. Invasive aspergillosis in patients with AIDS. Clin Infect Dis 19(Suppl 1): S41-48, 1994.
23. Hapholz A, Salomon N, Perlman DC, Talavera W. Aspergillosis in the acquired immunodeficiency syndrome. Chest 100:1614-18, 1991.
24. Levitz SM. Aspergillosis. Infect Dis Clin North Am 3:1-18, 1989.
25. Libanore M, Pastore A, Frasconi PC, Rossi MR, Bedetti A, Sighinolfi L, Ghinelli F. Invasive multiple sinusitis by Aspcrgillus fumigalus in a patient with AIDS. Int J STD AIDS 5:293-95, 1994.
26. Lortholary O, Meyohas M, Dupont B, Dupont B, Cadranel J, SalmonCeron D, Peyramond D, Simonin D. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: Report of 33 cases. Am J Med 95:177-87, 1993.
27. Meiteles LZ, Lucente FE. Sinus and nasal manifestations of the acquired immunodeficiency syndrome. Ear Nose Throat J 69:454-59, 1990.
28. Meyer RD, Gaultier CR, Yamashita JJ, Babapour R, Pithon HE, Wolf PR. Fungal sinusitis in patients with AIDS: Report of 4 cases and review of the literature. Medicine (Baltimore) 73:69-78, 1994.
29. Minamoto G, Barlam TF, Vander Els NJ. Invasive aspergillosis in patients with AIDS. Clin Infect Dis 14:66-74, 1992.
30. Morgan MA, Wilson WR, Neel HB HI, Roberts GD. Fungal sinusitis in healthy and immunocompromised individuals. Am J Clin Pathol 82: 597-601, 19S4.
31. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts: Proposed standards. Document M27-P. Villanova, PA: National Committee for Clinical Laboratory Standards, 1992.
32. Pervez NF, Heinerman J, Kattan M, Freed JA, Harris MB, Rosen MJ, Schwartz IS. Pseudomembranous necrotizing bronchial aspergillosis. Am Rev Respir Dis 131:961-63, 1985.
33. Pfaller MA, Bale M, Buschelman B, Lanchaster M, Espinel-ingroff A, Rex JH, Rinaldi MG, Cooper CR, McGinnis MR. Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing for amphotericin B, fluconazole, and flucytosine, J Clin Microbiol 33:1104-7, 1995.
34. Rubin JS, Honigberg R. Sinusitis in patients with the acquired immunodeficiency syndrome. Ear Nose Throat J 69:460-63, 1990.
35. Schaffner A. Pulmonary aspcrgillosis in AIDS [letter]. N Engl J Med 325:355-56, 1991.
36. Schnutgen M, Hohler T, Mayet WJ, Meyer zum Buschenfelde KH. Aspcrgillus-sinusitis in AIDS with rapid invasion of the orbita and the brain [abstract no. PO-BOO-1400]. In: Programs and abstracts of the IXth international conference on AIDS (Berlin), 1993.
37. Sennerille E, Chevalier D, Ajana F, Lecocq P, Chidiac C, Mouton Y. Management of acute sinusitis in people with HIV (PWII): The experience of a French AIDS Reference Centre (CISIH 18). Vlllth international conference on AIDS (Amsterdam), 1992.
38. Senneville E, Valette M, Lamy O, Chevalier D, Chidiac C, Mouton Y. Prevalence of maxillary sinusitis hi patients with HIV (PWII): Comparison with a control population (CP). 1st national conference on human retroviruses and related infections, 1993.
39. Small CB, Kaufman A, Armenaka M, Rosenstreich DL. Sinusitis and atropy in human immunodeficiency virus infection. J Infect Dis 167: 283-90, 1993.
40. Strauss M, Fine E. Aspergillus otomastoiditis in acquired immunodeficiency syndrome. Am J Otol 12:49-53, 1991.
41. Teh W, Matti BS, Marisiddaih H, Minamoto GY. Aspergillus sinusitis in patients with AIDS: Report of three cases and review. Clin Infect Dis 21:529-35, 1995.
42. Thomson C, Salvato P, Stroud S, Hasheeve D. Etiology of acute sinusitis in HTV infection [abstract WS-B08-6]. Iru Program and abstracts of the IXth international conference on AIDS (Berlin), 1993.
43. Upadhyay S, Marks SC, Arden RL, Crane LR, Cohn AM. Bacteriology of sinusitis in human immunodeficiency virus-positive patients: Implications for management. Laryngoscope 105:1058-60, 1995.
44. Villars W, Jones TC. Special features of the clinical use of oral terbinafine in the treatment of fungal diseases. Br J Dermatol 126 (Suppl39):61-59, 1992.
45. Vitale AT, Spaide RF, Warren FA, Moussouris HF, D'Amico RA. Orbita] aspergillosis in an immunocompromised host. Am J Opthalmol 113: 725-26, 1992.
46. Weber RS, Lopez-Berestein G. Treatment of invasive Aspergillus sinusitis with liposomal-amphotericin B. Laryngoscope 97:937-41, 1987.
47. Wiest PM, Wiese K, Jacobs MR, et al. Alternaria infection in a patient with acquired immunodeficiency syndrome: Case report and review of invasive alternaria infections. Rev Infect Dis 9:799-803, 1987.
48. Yousem DM. Imaging of the sinonasal inflamatory disease. Radiology 188: 303-14, 1993.
49. Zylberberg L, Havard S, Gorin I, Lacau St Guily J, Benoudiba D, Escande JP. Laryngeal aspergillosis. A case treated with itraconazole [abstract PO-B0901396]. In: Program and abstracts of the IXth international conference on AIDS (Berlin), 1993.